Specific humoral response in cancer patients treated with a VEGF-specific active immunotherapy procedure within a compassionate use program.

Sánchez Ramírez, Javier; Morera Díaz, Yanelys; Bequet-Romero, Mónica; Hernández-Bernal, Francisco; Martín Bauta, Yenima; Selman-Housein Bernal, Katty-Hind; de la Torre Santos, Ana Victoria; Pérez de la Iglesia, Mariela; Trimiño Lorenzo, Lian; Ayala Avila, Marta

Sánchez Ramírez, Javier; Morera Díaz, Yanelys; Bequet-Romero, Mónica; Hernández-Bernal, Francisco; Martín Bauta, Yenima; Selman-Housein Bernal, Katty-Hind; de la Torre Santos, Ana Victoria; Pérez de la Iglesia, Mariela; Trimiño Lorenzo, Lian; Ayala Avila, Marta.

Afiliação

Sánchez Ramírez J; Department of Pharmaceuticals, Center of Genetic Engineering and Biotechnology (CIGB), Playa, 10600, Havana, Cuba. javier.sanchez@cigb.edu.cu.
Morera Díaz Y; Department of Pharmaceuticals, Center of Genetic Engineering and Biotechnology (CIGB), Playa, 10600, Havana, Cuba.
Bequet-Romero M; Department of Pharmaceuticals, Center of Genetic Engineering and Biotechnology (CIGB), Playa, 10600, Havana, Cuba.
Hernández-Bernal F; Department of Clinical Research, CIGB, Playa, 10600, Havana, Cuba.
Martín Bauta Y; Department of Clinical Research, CIGB, Playa, 10600, Havana, Cuba.
Selman-Housein Bernal KH; Center of Medical and Surgical Research (CIMEQ), Playa, 12100, Havana, Cuba.
de la Torre Santos AV; "Celestino Hernández" Hospital, 50100, Santa Clara, Villa Clara, Cuba.
Pérez de la Iglesia M; Development Unit, CIGB, Playa, 10600, Havana, Cuba.
Trimiño Lorenzo L; Development Unit, CIGB, Playa, 10600, Havana, Cuba.
Ayala Avila M; Department of Pharmaceuticals, Center of Genetic Engineering and Biotechnology (CIGB), Playa, 10600, Havana, Cuba.

BMC Immunol ; 21(1): 12, 2020 03 14.

Article em En | MEDLINE | ID: mdl-32171254

Assuntos

Vacinas Anticâncer/imunologia; Imunoterapia Ativa/métodos; Neoplasias/imunologia; Proteolipídeos/imunologia; Fator A de Crescimento do Endotélio Vascular/imunologia; Adjuvantes Imunológicos; Ensaios de Uso Compassivo; Feminino; Humanos; Imunidade Humoral; Imunoglobulina A/sangue; Imunoglobulina G/sangue; Imunoglobulina M/sangue; Masculino; Pessoa de Meia-Idade; Neoplasias/terapia; Resultado do Tratamento; Vacinação; Fator A de Crescimento do Endotélio Vascular/genética; Fator A de Crescimento do Endotélio Vascular/metabolismo

Palavras-chave

CIGB-247; Cancer patients; Compassionate use program; Humoral response; Specific active immunotherapy; VEGF cancer vaccine

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 Base de dados: MEDLINE Assunto principal: Proteolipídeos / Imunoterapia Ativa / Vacinas Anticâncer / Fator A de Crescimento do Endotélio Vascular / Neoplasias Limite: Female / Humans / Male / Middle aged Idioma: En Revista: BMC Immunol Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google